A Novel Insight into the Cardiotoxicity of Antineoplastic Drug Doxorubicin

Nanoscaled Poly(l-glutamic acid)/Doxorubicin-Amphiphile Complex as pH-responsive Drug Delivery System for Effective Treatment of Nonsmall Cell Lung Cancer

(2013) Mingqiang Li et al.   ACS Applied Materials & Interfaces

Cucumber mosaic virus as drug delivery vehicle for doxorubicin

(2013) Qingbing Zeng et al.   BIOMATERIALS

G-protein Inactivator RGS6 Mediates Myocardial Cell Apoptosis and Cardiomyopathy Caused By Doxorubicin

(2013) J. Yang et al.   CANCER RESEARCH

Amino acids as metabolic substrates during cardiac ischemia

(2013) Kenneth J Drake et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Trastuzumab-induced cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and protective factors

(2013) Alberto Farolfi et al.   HEART

Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively

(2013) Ronald G. Schwartz et al.   JOURNAL OF NUCLEAR CARDIOLOGY

A Novel Self-Assembly Albumin Nanocarrier for Reducing Doxorubicin-Mediated Cardiotoxicity

(2013) Ahu Yuan et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Effects of leucine and its metabolite β-hydroxy-β-methylbutyrate on human skeletal muscle protein metabolism

(2013) D. J. Wilkinson et al.   JOURNAL OF PHYSIOLOGY-LONDON

3,3′-Diindolymethane ameliorates adriamycin-induced cardiac fibrosis via activation of a BRCA1-dependent anti-oxidant pathway

(2013) Zhengwei Yao et al.   PHARMACOLOGICAL RESEARCH

Comparative Cardiac Toxicity of Anthracyclines In Vitro and In Vivo in the Mouse

(2013) Stefano Toldo et al.   PLoS One

Weekly Doxorubicin Increases Coronary Arteriolar Wall and Adventitial Thickness

(2013) Delrae M. Eckman et al.   PLoS One

Leucine and Protein Metabolism in Obese Zucker Rats

(2013) Pengxiang She et al.   PLoS One

Left Ventricular Assist Device Effects on Metabolic Substrates in the Failing Heart

(2013) Lindsay B. Weitzel et al.   PLoS One

Fabrication and Intracellular Delivery of Doxorubicin/Carbonate Apatite Nanocomposites: Effect on Growth Retardation of Established Colon Tumor

(2013) Sharif Hossain et al.   PLoS One

Effectiveness of treatment summaries in increasing breast and colorectal cancer survivors’ knowledge about their diagnosis and treatment

(2013) Mary Jo Nissen et al.   Journal of Cancer Survivorship

Spectrometric and Chromatographic Study of Reactive Oxidants Hypochlorous and Hypobromous Acids and Their Interactions with Taurine

(2012) Lukas Nejdl et al.   CHROMATOGRAPHIA

Qualitative and quantitative analysis of thermosensitive liposomes loaded with doxorubicin

(2012) E. V. Tazina et al.   PHARMACEUTICAL CHEMISTRY JOURNAL

Probing the Binding Sites of Antibiotic Drugs Doxorubicin and N-(trifluoroacetyl) Doxorubicin with Human and Bovine Serum Albumins

(2012) Daniel Agudelo et al.   PLoS One

Withaferin A Synergizes the Therapeutic Effect of Doxorubicin through ROS-Mediated Autophagy in Ovarian Cancer

(2012) Miranda Y. Fong et al.   PLoS One

Doxorubicin induced dilated cardiomyopathy in a rabbit model: An update

(2012) Fábio N. Gava et al.   RESEARCH IN VETERINARY SCIENCE

Doxorubicin induced myocardial injury is exacerbated following ischaemic stress via opening of the mitochondrial permeability transition pore

(2012) M. Gharanei et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Taurine protects rat testes against doxorubicin-induced oxidative stress as well as p53, Fas and caspase 12-mediated apoptosis

(2011) Joydeep Das et al.   AMINO ACIDS

Branched-chain amino acid metabolism in heart disease: an epiphenomenon or a real culprit?

(2011) Y. Huang et al.   CARDIOVASCULAR RESEARCH

Encapsulation of cardiac stem cells in superoxide dismutase-loaded alginate prevents doxorubicin-mediated toxicity

(2011) Ting Chu Ken Liu et al.   Journal of Tissue Engineering and Regenerative Medicine

Anthracyclines and ellipticines as DNA-damaging anticancer drugs: Recent advances

(2011) Rene Kizek et al.   PHARMACOLOGY & THERAPEUTICS

Cardiomyocyte Specific Ablation of p53 Is Not Sufficient to Block Doxorubicin Induced Cardiac Fibrosis and Associated Cytoskeletal Changes

(2011) Tiam Feridooni et al.   PLoS One

Impaired overload-induced hypertrophy is associated with diminished mTOR signaling in insulin-resistant skeletal muscle of the obese Zucker rat

(2010) Anjaiah Katta et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Manganese superoxide dismutase: beyond life and death

(2010) Aaron K. Holley et al.   AMINO ACIDS

MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice

(2010) Denghong Zhang et al.   JOURNAL OF CLINICAL INVESTIGATION

Controlled Release of Doxorubicin from Doxorubicin/γ-Polyglutamic Acid Ionic Complex

(2010) Bhavik Manocha et al.   Journal of Nanomaterials

The role of the mitochondrial permeability transition pore in heart disease

(2009) Andrew P. Halestrap et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts

(2009) Vilma A. Sardão et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

What is the mitochondrial permeability transition pore?

(2009) Andrew P. Halestrap   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

More Than Bricks and Mortar: Comments on Protein and Amino Acid Metabolism in the Heart

(2008) Heinrich Taegtmeyer et al.   AMERICAN JOURNAL OF CARDIOLOGY

In Vitroandin VivoEvaluation of Doxorubicin Conjugates with the Divalent Peptide E-[c(RGDfK)2] that Targets Integrin αvβ3

(2008) Claudia Ryppa et al.   BIOCONJUGATE CHEMISTRY

SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth

(2008) Thomas Porstmann et al.   Cell Metabolism

Anthracycline Cardiotoxicity: From Bench to Bedside

(2008) Luca Gianni et al.   JOURNAL OF CLINICAL ONCOLOGY